Journal of Oncology Translational Research

cancer, NHS, UK, UK

Publications

• Short Communication   
  Rationale for Clinical Use of Drugs in Prostate Cancer Patients
  Author(s): S. Kushnow
  
  The absence of curative therapies for advanced or recurrent forms of prostate cancer mandates continued development of novel, more effective treatment regimens. Due to recent advances in basic and translational research, therapeutic vaccines and monoclonal antibody-based therapies are steadily gaining ground as promising treatment modalities against prostate cancer. Several immunotherapeutic products have recently been investigated in later-phase trials and have reported evidence for clinical benefit while maintaining an excellent quality of life for participants. The cumulative clinical results available to date indicate that immune-based therapies will likely play a role in the treatment of patients with prostate and other malignancies. The objective of this article is to increase awareness of contemporary immunologic therapies and clinical trials of new biologic reagents against pr.. Read More»
  DOI: 10.37421/2476-2261.2024.10.264

  Abstract HTML PDF